| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.004 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |